Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Viewpoint: AHSNs, AAR And Accelerators – Market Access & Innovation Update

Executive Summary

Dr Charlie Davie, managing director of UCLPartners, a London-based Academic Health Science Partnership and one of the 15 UK Academic Health Science Networks, updates Medtech Insight on key changes in NHS market access policy this summer.

Advertisement

Related Content

UK Medtech To Leverage Accelerated Access Opportunity, Regardless Of The 'B' Word
Moonshot Projects In Life Sciences Strategy Can Lift UK Over Brexit Hurdle
Digital Update: UK Peer Pressure, US Tech Advances And EU Common Goals Put eHealth To Top Of Agenda
UK Device, IVD Sector Cheered By New Funding Pledge For Accelerated Access Program
UK Viewpoint: Tech & Innovation In Focus In NHS Chief's 'Forward View'
UK Extols NHS Asset In The ‘No Plan B’ Post-Brexit World
UK’s New Care Models Must Factor In Innovation

Topics

Advertisement
UsernamePublicRestriction

Register

MT105315

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel